摘要
用于治疗骨丢失相关疾病如骨质疏松症和转移性骨病的当前治疗药物具有有限的临床结果,即在效率和可持续性方面。 鉴于发达国家的人口老龄化和治疗的累积成本,与骨丢失相关的疾病在世界范围内代表着重大的社会经济负担。 在本综述中,总结临床和临床前试验中针对骨损失的治疗剂以及临床医生和患者遇到的挑战。 为了实现成本效益的临床结果,公开了潜在的细胞和信号传导目标。
关键词: 骨丢失,治疗,合成代谢剂,抗吸收剂,临床试验,破骨细胞,成骨细胞。
图形摘要
Current Drug Targets
Title:Therapeutic Drugs in Bone Loss-Associated Disorders: Clinical Outcomes and Challenges
Volume: 18 Issue: 6
关键词: 骨丢失,治疗,合成代谢剂,抗吸收剂,临床试验,破骨细胞,成骨细胞。
摘要: Current therapeutic drugs for the treatment of bone loss-associated disorders such as osteoporosis and metastatic bone disease have limited clinical outcomes, namely in terms of efficiency and sustainability. Given the ageing of population in developed countries and the cumulative costs with treatment, bone loss-associated disorders represent a major socioeconomic burden worldwide. In this review, the therapeutic agents targeting bone loss tested in clinical and pre-clinical trials are summarized, as well as the challenges encountered by clinicians and patients. In an effort to attain costeffective clinical outcomes, potential cellular and signalling targets are disclosed.
Export Options
About this article
Cite this article as:
Therapeutic Drugs in Bone Loss-Associated Disorders: Clinical Outcomes and Challenges, Current Drug Targets 2017; 18 (6) . https://dx.doi.org/10.2174/1389450117666160709024547
DOI https://dx.doi.org/10.2174/1389450117666160709024547 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MicroRNA in Cervical Carcinogenesis: Window of Therapeutic Potential
Current Women`s Health Reviews Natural Product Inhibitors of the Ubiquitin-Proteasome Pathway
Current Drug Targets Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy
Current Pharmaceutical Biotechnology Current and Potential Treatments for Cervical Cancer
Current Cancer Drug Targets The Functional Role of Long Non-coding RNA UCA1 in Human Multiple Cancers: a Review Study
Current Molecular Medicine Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Topics in Medicinal Chemistry High-Content Analysis of Kinase Activity in Cells
Combinatorial Chemistry & High Throughput Screening Anti-Cancer Properties of Nigella spp. Essential Oils and their Major Constituents, Thymoquinone and β-Elemene
Current Clinical Pharmacology Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity
Current Medicinal Chemistry Prospects for Anti-Neoplastic Therapies Based on Telomere Biology
Current Cancer Drug Targets Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review
Recent Patents on Anti-Cancer Drug Discovery Targeting the Mitochondrial Electron Transport Chain Complexes for the Induction of Apoptosis and Cancer Treatment
Current Pharmaceutical Biotechnology Calpain-Associated Proteolytic Regulation of the Stromal Microenvironment in Cancer
Current Pharmaceutical Design Quercetin and MicroRNA Interplay in Apoptosis Regulation in Ovarian Cancer
Current Pharmaceutical Design Liposomes: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design The Metastatic Process: Methodological Advances and Pharmacological Challenges
Current Medicinal Chemistry Role of microRNAs in Osteoblasts Differentiation and Bone Disorders
Current Medicinal Chemistry Post-Translational Control of Sp-Family Transcription Factors
Current Genomics Chemokines and Their Receptors: Potential Therapeutic Targets for Bone Cancer Pain
Current Pharmaceutical Design Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer
Current Molecular Imaging (Discontinued)